ESC 365 - The impact of Covid-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 2020

ESC Professional Premium Access

The impact of Covid-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 2020

Session: Arterial occlusive disease: a chronic pandemic needing attention to detail

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor C. Hehrlein (Freiburg, DE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Professor Christoph Hehrlein

University Medical Center Freiburg, Freiburg (Germany)

0 follower

8 more presentations in this session

Reduction in the risk of major adverse limb events with ezetimibe versus placebo in addition to statin therapy: insights from the IMPROVE IT trial

Speaker: Doctor M. Bonaca (Aurora, US)

Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease

Speaker: Doctor M. Bonaca (Aurora, US)

Association between electronic nicotine delivery systems use and risk of stroke: A systematic review and meta-analysis of observational studies with 822,162 participants.

Speaker: Professor M. Banach (Lodz, PL)

Olive extract enriched with hydroxytyrosol improves cardiac and vascular function in patients with stable coronary artery disease: a double-blind, placebo-controlled trial.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Of mice and men: transcriptome-based clustering reveals molecular heterogeneity among mouse atherosclerosis models and partially reflects the diversity of human plaques

Speaker: Mr E. Brouwer (Utrecht, NL)

Access the full session

Arterial occlusive disease: a chronic pandemic needing attention to detail

Speakers: Professor C. Hehrlein, Doctor M. Bonaca, Doctor M. Bonaca, Professor M. Banach, Doctor I. Ikonomidis...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by